Thermo Fisher Scientific Inc. (TMO:NYSE) closed at $680.28 on October 22, 2026, down 1.98% on the day. The stock trades 3.6% below its 52-week high of $705.79 and 56.3% above its 52-week low of $435.27. Over the past year, it gained 22.4%. Thermo Fisher Scientific Inc. is part of the Capital Goods sector (Industrial Machinery/Components).
In 252 trading sessions since October 21, 2025, TMO closed higher on 130 days (52%). Its best day was July 23, 2026 (+8.71%) and its worst was April 23, 2026 (-9.20%). It never moved 10% or more in a single session. It opened at least 5% above the previous day's high 1 time.
Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Its Analytical Instruments segment offers instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. Its Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; blood-test systems to support clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; dehydrated...
Find more stocks like TMO with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.